AD biomarker profile | ||||
---|---|---|---|---|
A-T- | A+T- | A+T+ | ||
Baseline volume (ml) | CSO-PVS | 1.93±0.13 | 1.63±0.22 | 1.60±0.25 |
BG-PVS | 0.60±0.03 | 0.52±0.05 | 0.44±0.05 | |
12-month follow-up volume (ml) | CSO-PVS | 2.06±0.15 | 1.81±0.25 | 1.62±0.29 |
BG-PVS | 0.62±0.03 | 0.54±0.05 | 0.51±0.05 | |
24-month follow-up volume (ml) | CSO-PVS | 1.92±0.14 | 1.89±0.23 | 1.85±0.26 |
BG-PVS | 0.63±0.03 | 0.55±0.05 | 0.50±0.05 | |
36-month follow-up volume (ml) | CSO-PVS | 2.12±0.17 | 1.87±0.29 | 1.99±0.36 |
BG-PVS | 0.63±0.03 | 0.54±0.05 | 0.54±0.07 | |
Annual changea of PVS (in ml/year) | CSO-PVS | 0.04±0.04 | 0.08±0.03 | 0.14±0.03 |
BG-PVS | 0.01±0.00 | 0.01±0.01 | 0.03±0.01 | |
Annual change a of PVS from baseline (in %/year) | CSO-PVS | 2.21 | 4.76 | 9.03 |
BG-PVS | 1.59 | 1.26 | 6.61 |